Objective
Extracellular traps-(ETs) consist of DNA-protein-complexes formed following tissue injury contributes to the inflammatory and thrombosis cascades thereby exacerbating injury. Exogenous DNase-1 has been suggested as a therapeutic strategy to limit injury in the brain and myocardium.. These studies were designed to evaluate the effects of exogenous DNase-I treatment on skeletal muscle injury following acute hind limb ischemia-reperfusion (IR) injury in mice, and to determine whether neutrophils were a major source of ETs in postischemic muscle tissue.
Methods
C57BL6 mice were subjected to 1.5 hrs tourniquet ischemia and 24 hrs reperfusion with and without human recombinant DNase-I treatment. A separate set of mice was subjected to neutrophil depletion, followed by the same intervals of IR. Laser Doppler imaging and tissue harvesting was done at 24 hrs for assessment of limb perfusion, muscle fiber injury, ATP, markers of inflammation, thrombosis, and ETs formation.
Results
DNase-I treatment significantly reduced ETs detection in post-ischemic muscle but did not alter skeletal muscle fiber injury, levels of pro-inflammatory molecules or ATP. DNase-I treatment did enhance postischemic hind limb perfusion, decreased infiltrating inflammatory cells and reduced the expression of Thrombin-Anti-Thrombin-III. Neutrophil depletion resulted in a significant yet small reduction in ETs in the post ischemic muscle. Neutrophil depletion did not alter skeletal muscle fiber injury, hind limb perfusion, or ATP levels.
Conclusions
These data suggest that neither DNase-I treatment nor Neutrophil depletion were protective against IR injury, even though both decreased ETs detection in skeletal muscle following IR. Neutrophils are not the only source of ETs following IR.